Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 88, Issue 2, 1998, Pages 298-303

  Horky, Laura L ^a   Pluta, Ryszard M ^a   Boock, Robert J ^a   Oldfield, Edward H ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cynomolgous monkey; Dipyridyl; Ferrous iron chelator; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

2,2' BIPYRIDINE; DEFEROXAMINE; FERROUS ION; FREE RADICAL; IRON CHELATE; OXYHEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN VASOSPASM; CONTROLLED STUDY; CRANIOTOMY; DOSE RESPONSE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; IRON CHELATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONKEY; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

EID: 0031882508     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.88.2.0298     Document Type: Article

References (51)

1. Afshar JKB, Pluta RM, Boock RJ, et al: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118-122, 1995
2. Asano T, Matusi T, Takuwa Y: Reappraisal of the role of lipid peroxidation in the pathogenesis of vasospasm: relevance to protein kinase C activation, in San K, Takakura K, Kassell NF, et al (eds): Cerebral Vasospasm. Proceedings of the IVth International Conference on Cerebral Vasospasm, Tokyo, 1990. Tokyo: University of Tokyo Press, 1990, pp 65-70
3. Asano T, Tanishima T, Sasaki T, et al: Possible participation of free radical reactions initiated by clot lysis in the pathogenesis of vasospasm after subarachnoid hemorrhage, in Wilkins R (ed): Cerebral Arterial Spasm. Proceedings of the Second International Workshop. Amsterdam, The Netherlands, 1979. Baltimore: Williams & Wilkins, 1980, pp 190-201
4. Balla G, Vercellotti GM, Muller-Eberhard U, et al: Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64: 648-655, 1991
5. Balla J, Nath KA, Balla G, et al: Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol 268:L321-L327, 1995
6. Breuer W, Epsztejn S, Cabantchik ZI: Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron (II). J Biol Chem 270:2409-2415, 1995
7. Cohen G: The Fenton reaction, in Greenwald RA (ed): CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press, 1985, pp 55-58
8. Comair YG, Schipper HM, Brem S: The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskeletal injury by deferoxamine. Neurosurgery 32:58-65, 1993
9. Crow A, Morgan EH: Effects of chelators on iron uptake and release by the brain in the rat. Neurochem Res 19:71-76, 1994
10. Duff TA, Scott G, Feilbach JA: Ultrastructural evidence of arterial denervation following experimental subarachnoid hemorrhage. J Neurosurg 64:292-297, 1986
11. Espinosa F, Weir B, Overton T, et al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in mon-keys. Part 1: Clinical and radiological findings. J Neurosurg 60:1167-1175, 1984
12. Faraci FM: Endothelium-derived vasoactive factors and regulation of the cerebral circulation. Neurosurgery 33:648-659, 1993
13. Fox JL: Intracranial vascular smooth muscle: a study with iron compounds. Surg Neurol 11:363-368, 1979
14. Fuji S, Fujitsu K: Experimental vasospasm in cultured arterial smooth-muscle cells. Part 1. Contractile and ultrastructural changes caused by oxyhemoglobin. J Neurosurg 69:92-97, 1988
15. Gibson QH, Roughton FJW: The kinetics of equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol 136:507-526, 1957
16. Groce DF, Kimbrough RD: Acute and subacute toxicity in sherman strain rats exposed to 4,4′- and 2,2′dipyridyl. J Tox Envir Health 10:363-372, 1982
17. Haley EC Jr, Kassell NF, Alves WM, et al: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790, 1995
18. Harada T, Mayberg MR: Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine. J Neurosurg 77: 763-767, 1992
19. Hershko C, Weatheral DJ: Iron-chelating therapy. Crit Rev Clin Lab Sci 26:303-345, 1988
20. Iadecola C, Pelligrino DA, Moskowitz MA, et al: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14:175-192, 1994
21. Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30: 535-560, 1990
22. Ikeda Y, Ikeda K, Long DM: Comparative study of different iron-chelating agents in cold-induced brain edema. Neurosurgery 24:820-824, 1989
23. Kassell NF, Peerless SJ, Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337-343, 1982
24. Kassell NF, Sasaki T, Colohan ART, et al: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16: 562-572, 1985
25. Kawakami M, Kodama N, Toda N: Suppression of the cerebral vasospastic actions of oxyhemoglobin by ascorbic acid. Neurosurgery 28:33-40, 1991
26. Kikuchi G, Yoshida T: Function and induction of the microsomal heme oxygenase. Mol Cell Biochem 53/54:163-183, 1983
27. Kozlov AB, Ostrachovitch AA, Afanas'ev IB: Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates. Biochem Pharm 47:795-799, 1994
28. Lamontagne D, König A, Bassenge E, et al: Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol 20:652-657, 1992
29. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991
30. Macdonald RL, Weir BKA, Runzer TD, et al: Etiology of cerebral vasospasm in primates. J Neurosurg 75:415-424, 1991
31. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991
32. Nunez MT, Cole ES, Glass J: The reticulocyte plasma membrane pathway or iron uptake as determined by the mechanism of α-α′-dipyridyl inhibition. J Biol Chem 258:1146-1151, 1982
33. Oudibar M, Boquillon M, Marie C, et al: Ischemia-induced brain iron delocalization: effect of iron chelators. Free Rad Biol Med 16:861-867, 1994
34. Pearce W: Mechanism of hypoxic and hypercapnic cerebral vasodilation, in Bevan RD, Bevan JA (eds): The Human Brain Circulation. Functional Changes in Disease. Totawa, NJ: Humana Press, 1994, pp 195-200
35. Peters G, Keberle H, Schmid K, et al: Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem Pharmacol 15:93-109, 1966
36. Pirisino R, DiSimplico P, Ignesti G, et al: Sulfhydryl groups and peroxidase-like activity of albumin as scavenger of organic peroxides. Pharmacol Res Commun 20:545-552, 1988
37. Pluta RM, Oldfield EH, Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746-751, 1997
38. Pluta RM, Thompson BG, Dawson TM, et al: Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648-654, 1996
39. Pluta RM, Zauner A, Morgan JK, et al: Is vasospasm related to proliferative arteriopathy? J Neurosurg 77:740-748, 1992
40. Sano K, Asano T, Tanishima T, et al: Lipid peroxidase as a cause of cerebral vasospasm. Neurol Res 2:253-272, 1980
41. Sasaki T, Asano T, Sano K: [Cerebral vasospasm and free radical reactions.] Neurol Med Chir 20:145-153, 1980 (Jpn)
42. Sonobe M, Suzuki J: Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate. Acta Neurochir 44:97-106, 1978
43. Stone JR, Marletta MA: Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33:5636-5640, 1994
44. Takeda A, Onodera H, Sugimoto A, et al: Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res 666:120-124, 1994
45. Toda N, Ayajiki K, Yoshida K, et al: Impairment by damage of the pterygopalatine ganglion in nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. Circ Res 72:206-213, 1993
46. Vane JR, Änggård EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323:27-36, 1990
47. Vollmer DG, Hongo K, Ogawa H, et al: A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 28:27-32, 1991
48. Weir B, Grace M, Hansen J, et al: Time course of vasospasm in man. J Neurosurg 48:173-178, 1978
49. Weir B, Macdonald L: Cerebral vasospasm. Clin Neurosurg 40:40-55, 1993
50. Yosha T, Kobayashi Y, Masuko T: Differential effects of 3 dipyridyl isomers on hepatic microsomal cytochrome P450 and heme oxygenase in rat. Toxicol Lett 76:145-153, 1995
51. Young DS: Effects of Drugs on Clinical Laboratory Tests, ed 4. Washington, DC: AACC Press, 1995